Metastatic Nasopharyngeal Carcinoma

NCT06886347 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Nasopharyngeal Carcinoma

Interventions

DRUG: Penplimab Injection
DRUG: Antitinib Hydrochloride Capsules
DRUG: Gemcitabine

Sponsor

Chen Xiaozhong